Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 36


Shear stress increases ICAM-1 and decreases VCAM-1 and E-selectin expressions induced by tumor necrosis factor-[alpha] in endothelial cells.

Chiu JJ, Lee PL, Chen CN, Lee CI, Chang SF, Chen LJ, Lien SC, Ko YC, Usami S, Chien S.

Arterioscler Thromb Vasc Biol. 2004 Jan;24(1):73-9.


Differential role of MEK5alpha and MEK5beta in BMK1/ERK5 activation.

Cameron SJ, Abe J, Malik S, Che W, Yang J.

J Biol Chem. 2004 Jan 9;279(2):1506-12.


Inhibition of tumor necrosis factor-[alpha]-induced SHP-2 phosphatase activity by shear stress: a mechanism to reduce endothelial inflammation.

Lerner-Marmarosh N, Yoshizumi M, Che W, Surapisitchat J, Kawakatsu H, Akaike M, Ding B, Huang Q, Yan C, Berk BC, Abe J.

Arterioscler Thromb Vasc Biol. 2003 Oct 1;23(10):1775-81.


Role of phosphodiesterase 3 in NO/cGMP-mediated antiinflammatory effects in vascular smooth muscle cells.

Aizawa T, Wei H, Miano JM, Abe J, Berk BC, Yan C.

Circ Res. 2003 Sep 5;93(5):406-13.


Peroxisome proliferator-activated receptor gamma (PPARgamma) expression is decreased in pulmonary hypertension and affects endothelial cell growth.

Ameshima S, Golpon H, Cool CD, Chan D, Vandivier RW, Gardai SJ, Wick M, Nemenoff RA, Geraci MW, Voelkel NF.

Circ Res. 2003 May 30;92(10):1162-9.


Erk5 null mice display multiple extraembryonic vascular and embryonic cardiovascular defects.

Regan CP, Li W, Boucher DM, Spatz S, Su MS, Kuida K.

Proc Natl Acad Sci U S A. 2002 Jul 9;99(14):9248-53.


Insulin-like growth factor-1 enhances inflammatory responses in endothelial cells: role of Gab1 and MEKK3 in TNF-alpha-induced c-Jun and NF-kappaB activation and adhesion molecule expression.

Che W, Lerner-Marmarosh N, Huang Q, Osawa M, Ohta S, Yoshizumi M, Glassman M, Lee JD, Yan C, Berk BC, Abe J.

Circ Res. 2002 Jun 14;90(11):1222-30.


Hydrogen peroxide stimulates c-Src-mediated big mitogen-activated protein kinase 1 (BMK1) and the MEF2C signaling pathway in PC12 cells: potential role in cell survival following oxidative insults.

Suzaki Y, Yoshizumi M, Kagami S, Koyama AH, Taketani Y, Houchi H, Tsuchiya K, Takeda E, Tamaki T.

J Biol Chem. 2002 Mar 15;277(11):9614-21.


In vivo myocardial protection from ischemia/reperfusion injury by the peroxisome proliferator-activated receptor-gamma agonist rosiglitazone.

Yue Tl TL, Chen J, Bao W, Narayanan PK, Bril A, Jiang W, Lysko PG, Gu JL, Boyce R, Zimmerman DM, Hart TK, Buckingham RE, Ohlstein EH.

Circulation. 2001 Nov 20;104(21):2588-94.


Inflammatory pathways in atherosclerosis and acute coronary syndromes.

Plutzky J.

Am J Cardiol. 2001 Oct 18;88(8A):10K-15K. Review.


Troglitazone inhibits formation of early atherosclerotic lesions in diabetic and nondiabetic low density lipoprotein receptor-deficient mice.

Collins AR, Meehan WP, Kintscher U, Jackson S, Wakino S, Noh G, Palinski W, Hsueh WA, Law RE.

Arterioscler Thromb Vasc Biol. 2001 Mar;21(3):365-71.


Molecular cloning of mouse ERK5/BMK1 splice variants and characterization of ERK5 functional domains.

Yan C, Luo H, Lee JD, Abe J, Berk BC.

J Biol Chem. 2001 Apr 6;276(14):10870-8.


ERK5 is a novel type of mitogen-activated protein kinase containing a transcriptional activation domain.

Kasler HG, Victoria J, Duramad O, Winoto A.

Mol Cell Biol. 2000 Nov;20(22):8382-9.


Dynamic stabilization of nuclear receptor ligand binding domains by hormone or corepressor binding.

Pissios P, Tzameli I, Kushner P, Moore DD.

Mol Cell. 2000 Aug;6(2):245-53.


Peroxisome proliferator-activated receptor gamma ligands inhibit development of atherosclerosis in LDL receptor-deficient mice.

Li AC, Brown KK, Silvestre MJ, Willson TM, Palinski W, Glass CK.

J Clin Invest. 2000 Aug;106(4):523-31.


Src and Cas mediate JNK activation but not ERK1/2 and p38 kinases by reactive oxygen species.

Yoshizumi M, Abe J, Haendeler J, Huang Q, Berk BC.

J Biol Chem. 2000 Apr 21;275(16):11706-12.

Items per page

Supplemental Content

Support Center